Forge Therapeutics' Grant

Forge Therapeutics raised a round of funding on March 30, 2017. Investors include CARB-X.

Forge Therapeutics is a biotechnology company developing medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins.…

Articles about Forge Therapeutics' Grant: